- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
St. John's,NL
2013 FACE meeting
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy Forum
Archived Questions and AnswersThis Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
CCoPE
Date: 2007-01-19
Question:
Hi,
Please can you advise us on weather it is safe for a male to be taking hydroxyurea and wanting to conceive. Also if the male is going to freeze his sperm and he has been taking hydoxyurea, is it still safe .
Many thanks
preeti
Answer:
There isn?t much information on male use of hydroxyurea while wanting to conceive, nor is there much data on the transfer of medication to the sperm. There are no human studies of male use of hydroxyurea but animal studies have shown that hydroxyurea may cause testicular atrophy (Reprod Toxicol 9:21-33, 1995.), or it may change the shape and structure of the sperm (Cell Prolif 26:147-59, 1993.).
The impact of chemotherapy on male fertility depends on the treatment protocol as well as the pre-treatment rate of sperm formation in the male (JDDG 5:15?21, 2007). Sperm concentration starts to drop about 2 weeks after beginning chemotherapy and reaches a maximum after 2?3 months (Reprod Toxicol 2001; 15: 333?338.). About 50% of men show recovery of sperm concentrations after 12?36 months. One year after therapy is completed, a treated patient has no increased risk of fathering a malformed child (JDDG 5:15?21, 2007). The cryopreservation of sperm causes a loss of vital sperm by 30?70 %, but does not influence the genetic information of gametes (JDDG 5:15?21, 2007).
Presently there is no chemotherapeutic agent shown to cause malformations in humans after sperm exposure. It seems to be an "all or none' phenomenon, namely sperm count may be too low to father a child, or it is normal.












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)